Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Pronorvistaon Oct 31, 2023 3:45pm
183 Views
Post# 35709875

ATE

ATE

Market By Price

Price Total Volume Value
0.830 6,200 $5,146
0.800 2,000 $1,600
0.790 10,000 $7,900
0.780 5,000 $3,900
0.750 7,000 $5,250
0.740 2,500 $1,850
0.730 15,250 $11,132
0.720 5,500 $3,960
0.710 20,000 $14,200
0.700 6,500 $4,550
0.680 11,550 $7,854
0.670 2,500 $1,675
0.660 5,000 $3,300
0.650 11,000 $7,150
0.640 27,000 $17,280
0.630 21,700 $13,671
0.620 13,500 $8,370
0.610 15,000 $9,150
0.600 2,500 $1,500
0.590 22,000 $12,980
 

<< Previous
Bullboard Posts
Next >>